2009
DOI: 10.1111/j.1399-0039.2009.01393.x
|View full text |Cite
|
Sign up to set email alerts
|

HLA‐G and its relation to proliferation index in detection and monitoring breast cancer patients

Abstract: Recent studies indicate an ectopic upregulation of the human leukocyte antigen G (HLA-G) in tumor cells that may favor their escape from antitumor immune responses. The role of HLA-G in breast cancer has not been defined. Other studies showed that HLA-G transcription may be silenced by epigenetic mechanisms or activated by stress. This work aimed to clarify the expression of HLA-G protein, estimate the possible prognostic role of HLA-G expression and identify if this expression is linked to the DNA index (DI) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
19
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 45 publications
2
19
0
Order By: Relevance
“…Circulating sHLA-G levels are not significantly correlated to most clinicopathological parameters, such as the age of the patients, location, TNM stage, tumor stage, and nuclear grade, according to previous data [26], [27], [34]. Similarly, we also found no correlation between sHLA-G and the clinicopathological parameters of our sample population.…”
Section: Discussionsupporting
confidence: 51%
“…Circulating sHLA-G levels are not significantly correlated to most clinicopathological parameters, such as the age of the patients, location, TNM stage, tumor stage, and nuclear grade, according to previous data [26], [27], [34]. Similarly, we also found no correlation between sHLA-G and the clinicopathological parameters of our sample population.…”
Section: Discussionsupporting
confidence: 51%
“…To distinguish between viable, early apoptotic, and late apoptotic cells, the cells were washed and incubated in PBS containing 30% human AB serum (4°C for 30 min) prior to staining with Annexin V-FITC and propidium iodide (PI) (15 min at 25 °C) using a commercial kit according to the manufacturer's instructions (Abcam, Canada). The cells were analyzed by flow cytometry using a FACS Calibur flow cytometer (BD-Pharmingen) within 1 h of staining, and the percentage of cells undergoing apoptosis was determined [36, 37]. …”
Section: Methodsmentioning
confidence: 99%
“…Cell surface antigen expression was determined by single-parameter fluorescence-activated cell sorter (FACS) analysis as previously described [25][26][27] using the following monoclonal antibodies (mAbs): FITC-conjugated anti-CD4, FITC-conjugated anti-CD8, and FITC-conjugated mouse isotype-matched control mAbs, all purchased from BD Biosciences. After incubation in culture for 4 hours, PBMCs were washed 3 times in PBS, washed 2 times with FACS buffer (1% BSA in PBS) and then double stained with FITCconjugated anti-CD4 and FITC-conjugated anti-CD8 or -IgG2a isotype control at 10 µl of antibody/10 6 cells at 4°C for 30 minutes.…”
Section: Flow Cytometry Analysismentioning
confidence: 99%